The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light

    1. Izabela Ragan
    2. Lindsay Hartson
    3. Heather Pidcoke
    4. Richard Bowen
    5. Raymond Goodrich

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The UCSC SARS-CoV-2 Genome Browser

    1. Jason D. Fernandes
    2. Angie S. Hinrichs
    3. Hiram Clawson
    4. Jairo Navarro Gonzalez
    5. Brian T. Lee
    6. Luis R. Nassar
    7. Brian J. Raney
    8. Kate R. Rosenbloom
    9. Santrupti Nerli
    10. Arjun A. Rao
    11. Daniel Schmelter
    12. Alastair Fyfe
    13. Nathan Maulding
    14. Ann S. Zweig
    15. Todd M. Lowe
    16. Manuel Ares
    17. Russ Corbet-Detig
    18. W. James Kent
    19. David Haussler
    20. Maximilian Haeussler

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19

    1. Stuart A. MacGowan
    2. Geoffrey J. Barton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Temporal signal and the phylodynamic threshold of SARS-CoV-2

    1. Sebastian Duchene
    2. Leo Featherstone
    3. Melina Haritopoulou-Sinanidou
    4. Andrew Rambaut
    5. Philippe Lemey
    6. Guy Baele

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Computational analysis on the ACE2-derived peptides for neutralizing the ACE2 binding to the spike protein of SARS-CoV-2

    1. Cecylia S. Lupala
    2. Vikash Kumar
    3. Xuanxuan Li
    4. Xiao-dong Su
    5. Haiguang Liu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Computational methods to develop potential neutralizing antibody Fab region against SARS-CoV-2 as therapeutic and diagnostic tool

    1. Hemanth K. Manikyam
    2. Sunil K. Joshi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission

    1. Sayantan Laha
    2. Joyeeta Chakraborty
    3. Shantanab Das
    4. Soumen Kanti Manna
    5. Sampa Biswas
    6. Raghunath Chatterjee

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease

    1. Sebastian Günther
    2. Patrick Y. A. Reinke
    3. Dominik Oberthuer
    4. Oleksandr Yefanov
    5. Helen Ginn
    6. Susanne Meier
    7. Thomas J. Lane
    8. Kristina Lorenzen
    9. Luca Gelisio
    10. Wolfgang Brehm
    11. Illona Dunkel
    12. Martin Domaracky
    13. Sofiane Saouane
    14. Julia Lieske
    15. Christiane Ehrt
    16. Faisal Koua
    17. Alexandra Tolstikova
    18. Thomas A. White
    19. Michael Groessler
    20. Holger Fleckenstein
    21. Fabian Trost
    22. Marina Galchenkova
    23. Yaroslav Gevorkov
    24. Chufeng Li
    25. Salah Awel
    26. Ariana Peck
    27. P. Lourdu Xavier
    28. Miriam Barthelmess
    29. Frank Schlünzen
    30. Nadine Werner
    31. Hina Andaleeb
    32. Najeeb Ullah
    33. Sven Falke
    34. Bruno Alves Franca
    35. Martin Schwinzer
    36. Hévila Brognaro
    37. Brandon Seychell
    38. Henry Gieseler
    39. Diogo Melo
    40. Joanna I. Zaitseva-Kinneberg
    41. Brenna Norton-Baker
    42. Juraj Knoska
    43. Gisel Esperanza
    44. Aida Rahmani Mashhour
    45. Filip Guicking
    46. Vincent Hennicke
    47. Pontus Fischer
    48. Cromarte Rogers
    49. Diana C. F. Monteiro
    50. Johanna Hakanpää
    51. Jan Meyer
    52. Heshmat Noei
    53. Phil Gribbon
    54. Bernhard Ellinger
    55. Maria Kuzikov
    56. Markus Wolf
    57. Linlin Zhang
    58. Xinyuanyuan Sun
    59. Jonathan Pletzer-Zelgert
    60. Jan Wollenhaupt
    61. Christian Feiler
    62. Manfred Weiss
    63. Eike-Christian Schulz
    64. Pedram Mehrabi
    65. Christina Schmidt
    66. Robin Schubert
    67. Huijong Han
    68. Boris Krichel
    69. Yaiza Fernández-García
    70. Beatriz Escudero-Pérez
    71. Stephan Günther
    72. Dusan Turk
    73. Charlotte Uetrecht
    74. Tobias Beck
    75. Henning Tidow
    76. Ashwin Chari
    77. Andrea Zaliani
    78. Matthias Rarey
    79. Russell Cox
    80. Rolf Hilgenfeld
    81. Henry N. Chapman
    82. Arwen R. Pearson
    83. Christian Betzel
    84. Alke Meents

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

    1. Wayne Vuong
    2. Muhammad Bashir Khan
    3. Conrad Fischer
    4. Elena Arutyunova
    5. Tess Lamer
    6. Justin Shields
    7. Holly A. Saffran
    8. Ryan T. McKay
    9. Marco J. van Belkum
    10. Michael A. Joyce
    11. Howard S. Young
    12. D. Lorne Tyrrell
    13. John C. Vederas
    14. M. Joanne Lemieux

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays

    1. Erik Jue
    2. Rustem F. Ismagilov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 269 of 2361 Older